# Glenmark Pharmaceuticals Limited – FDA Inspection, Feb 21, 2020

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/7480abca-376a-48b0-8d6c-47a32ec70561
Source feed: FDA_Inspections

> FDA inspection 1122444 of Glenmark Pharmaceuticals Limited, February 21, 2020. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122444
- Company Name: Glenmark Pharmaceuticals Limited
- Inspection Date: 2020-02-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1298220 - 2025-11-28
- FDA Inspection 1252922 - 2024-09-20
- FDA Inspection 1226884 - 2023-12-15
- [FDA Inspection 1065438 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/84e00ca0-c1d9-49f1-aa35-11332d0d7eec)
- FDA Inspection 1025068 - 2017-07-21

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/dacc6330-129c-4ce4-8c41-f71525daebe5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c